Babson Diagnostics
Babson Diagnostics is a medical technology company offering decentralized diagnostic blood testing through its BetterWay service, enabling finger-prick capillary blood collection at retail pharmacies without trained phlebotomists for patients and healthcare systems.
- Company typePrivate
- Founded2017
- HeadquartersAustin, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Babson Diagnostics does
Babson generates revenue through transaction fees on its BetterWay blood testing service, sold primarily via retail pharmacy distribution channels (including CVS, Walgreens, and independent pharmacies) and community-based healthcare settings. Its go-to-market combines channel partnerships through pharmacy networks and BD's healthcare system relationships with an enterprise field sales motion targeting U.S. healthcare systems for chronic disease monitoring and preventative testing use cases. Customer segments span retail pharmacy networks (primary), U.S. healthcare systems, and community-based settings including a 2026 clinical affiliation with the UT Austin School of Nursing for underserved-population outreach. The company operates exclusively in Texas and has 51-100 employees. Total disclosed funding is approximately $44.7 million across a 2020 round led by Genesis Merchant Capital and a 2021 Series B led by Emerald Development Managers with participation from Siemens Healthineers, Prism Ventures, and Lago Consulting Group.
Babson Diagnostics firmographics
Firmographics- Name
- Babson Diagnostics
- Legal name
- Babson Diagnostics
- Website
- https://babsondx.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Babson Diagnostics is a medical technology company offering decentralized diagnostic blood testing through its BetterWay service, enabling finger-prick capillary blood collection at retail pharmacies without trained phlebotomists for patients and healthcare systems.
- Ownership category
- akta.pro rank
Babson Diagnostics industry classification
Industry- Product category
- Diagnostic Blood Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
- akta.pro secondary industries
- Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK), Urinalysis & Routine Screening Diagnostics (HLAHAAAG)
Keywords
Where Babson Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Babson Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Blood Testing Services: Babson Diagnostics generates revenue through its BetterWay blood testing service, providing diagnostic blood tests at retail pharmacy locations. The service enables routine wellness screenings and chronic disease monitoring with decentralized testing capabilities.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels2 records
Babson Diagnostics product offering
Product offeringCore offering
Babson Diagnostics operates the BetterWay Blood Testing service, a decentralized diagnostic testing model that uses proprietary finger-prick capillary blood collection devices and sample-handling machines to deliver venous-quality laboratory results from a few drops of blood. The service is delivered primarily through retail pharmacy locations and community-based settings without requiring trained phlebotomists, and is extended to healthcare systems via the BD MiniDraw Capillary Blood Collection System co-developed with Becton Dickinson.
Product overview
Babson Diagnostics offers a single unified product called BetterWay Blood Testing, a decentralized diagnostic service that combines finger-prick capillary blood collection technology with laboratory analysis to deliver venous-quality results. The service enables routine medical tests from small blood samples in pharmacies, clinics, and community settings without requiring trained phlebotomists, expanding patient access to preventative testing and chronic disease monitoring through retail pharmacy networks.
Differentiator
Problem solved
Functional benefit
Products and services
- BetterWay Blood Testing
Quantifiable outcome
- Clinical studies show finger-prick tests are clinically equivalent to standard venous tests
Companies that use Babson Diagnostics
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Babson Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Babson Diagnostics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- University of Texas at Austin School of NursingcoreFive-year clinical affiliation agreement with UT Austin School of Nursing through the city-funded AMEN project. Babson Diagnostics provides training, collection devices, laboratory testing, and supervision as nursing students perform capillary blood collections during community outreach events serving underserved populations. 26 students already trained with 10 currently enrolled students having completed training and participated in three outreach events.
- Becton Dickinson (BD)flagshipStrategic partnership to develop and distribute the BD MiniDraw Capillary Blood Collection System. BD and Babson Diagnostics are advancing decentralized diagnostic testing through finger-prick blood collection systems that deliver venous-quality results from small samples. The partnership enables routine wellness screenings and chronic disease monitoring in pharmacies and community-based settings.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Babson Diagnostics competitors and assessment
Company assessmentPeers
Direct peers
- Drawbridge Health: Drawbridge Health developed the OneDraw capillary blood collection device for decentralized diagnostic testing. It is the closest direct competitor to Babson in the finger-prick, retail-amenable sample collection category, with similar target use cases in routine screening and chronic disease monitoring.
- Tasso Inc. Tasso manufactures the Tasso OnDemand and Tasso Plus capillary blood collection devices used in decentralized clinical trials and remote testing. It competes directly with Babson/BD MiniDraw in the capillary sample collection category and serves overlapping pharma, clinical research, and at-home diagnostics customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Babson Diagnostics social profiles
Digital presenceBabson Diagnostics compliance and trust
Trust signalCompliance1 record
Babson Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Babson Diagnostics leadership team
Management profileNumber of profiles
Profiles3 records
Babson Diagnostics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Babson Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Babson Diagnostics
What does Babson Diagnostics do?
Babson Diagnostics operates the BetterWay Blood Testing service, a decentralized diagnostic testing model that uses proprietary finger-prick capillary blood collection devices and sample-handling machines to deliver venous-quality laboratory results from a few drops of blood. The service is delivered primarily through retail pharmacy locations and community-based settings without requiring trained phlebotomists, and is extended to healthcare systems via the BD MiniDraw Capillary Blood Collection System co-developed with Becton Dickinson.
Is Babson Diagnostics a public or private company?
Babson Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Babson Diagnostics founded?
Babson Diagnostics was founded in 2017. It employs 51 to 100 people.
Where is Babson Diagnostics based?
Babson Diagnostics is headquartered in Austin, United States, in the North America region.
How does Babson Diagnostics make money?
One revenue line is on record: blood Testing Services.
Who are Babson Diagnostics's main competitors?
Yourbio Health is listed as a peer. Direct peers are Drawbridge Health and Tasso Inc..
Does Babson Diagnostics have an API?
No public API is recorded for Babson Diagnostics.
What industry is Babson Diagnostics in?
Babson Diagnostics's product category is Diagnostic Blood Testing Services. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGAEAK, Point-of-Care & Decentralized Trial Testing Services. Its NAICS code is 621511 and its SIC code is 8071.